Drugs / α-lipoic acid
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 31 trial · 1 missed | ||||||
| Phase 3 | NCT00116207 | Jan 2000 → Sep 2009 | diabetic autonomic neuropathy | University of Michigan | Completed | Missed primary |
| Comparator or background therapy3 trials | ||||||
| Phase 4 | NCT02056366 Comparator | Jan 2010 → Sep 2013 | diabetic autonomic neuropathy, type 2 diabetes mellitus | The Catholic University of Korea | Completed | No outcome recorded |
| — | NCT03601494 Comparator | Feb → Nov 2017 | chronic pain syndrome, diabetic neuropathy | Assiut University | Completed | No outcome recorded |
| — | NCT02971878 Comparator | Nov 2016 → Feb 2018 | — | Fertilitetscentrum AB | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | α-lipoic acid | “antioxidant treatment with allopurinol, α-lipoic acid and nicotinamide, or placebo.” PMID 23740194 ↗ Jun 20133“vitamin B complex, α lipoic acid, selective serotonin reuptake inhibitor (SSRI)” NCT03601494 ↗ |
| Known as | ALA | “Human embryos will be cultured in media that contains 3 antioxidants (Acetyl-L-carnitine (ALC), N-acetyl-L-cysteine (NAC) and α-lipoic acid (ALA)) that can be found in the in...” NCT02971878 ↗ |
| Route | Oral | “α-lipoic acid 600mg PO medication,Per day, For 6weeks α-lipoic acid 1200mg PO medication,Per day, For 6weeks” NCT02056366 ↗ |